SOURCE: annual_report_text (1).txt
CHUNK: 502 of 1106
SIZE: 608 characters
PREVIOUS: chunk_0501_annual_report_text (1).txt
NEXT: chunk_0503_annual_report_text (1).txt
------------------------------
=== Page 98 ===
IBA Annual Report 2023 
95. IBA 
to a streghtened backlog conversion in H2. We 
also see a good order intake for Other 
Accelerators, as well as continued growth for 
Dosimetry. For the year ended on December 31, 2023, the 
Group 
gross 
margin 
(31.4%) 
worsened 
compared to 2022 (35.1%) following inflation 
and lower overhead absorption. The previous 
year performance was also positively impacted 
by indemnities related to the Rutherfords 
bankruptcy. As of December 31, 2023, the Group operating 
expenses were EUR 128.0 million, a 10.6%% 
increase from 2022 (2022: EUR 115.7 million).